You are here

P&T News

October 9

Scenesse is new treatment for people with rare, painful light sensitivity disease
Humira, Rituxan top list of drugs that added $5.1 billion to nation's health care bill
Lower court rulings cleared the way for generic versions of the MS drug
Maryland man wins lawsuit that alleges that the company's antipsychotic caused his gynecomastia
Antidepressants, ADHD meds are also used to self-poison

October 8

Study lists steps that could save close to $300 billion a year
While many victims used THC, the cause remains elusive
Descovy joins Truvada, another Gilead product, in the HIV prophylaxis market
Data show PTC Therapeutics drug preserves lung function
U.S. maintains measles elimination status as NY outbreak ebbs

October 3

Rodent model suggests that TOM-1 protein may control key step in inflammatory underpinnings
Results based on 60 years of follow-up of a placebo-controlled BCG study conducted among Native Americans

October 2

Controversial review contradicts prevailing wisdom about negative health consequences of red, processed meat consumption
Addition of the checkpoint inhibitor increased complete response
A positive sign for PARP inhibitors as treatment drugs for prostate cancer

September 26

Bleeding Risk Means Patients Should Consult With Physician Before Taking Aspirin
First Oral Formulation in the GLP-1 Class
TIMP-1, IL-6 Seem To Team Up To Fend Off Tx drugs
Study of Mixed Martial Arts Fighters, Rugby Players Could Lead to Improved Dx of TBI
Lifestyle Apps Will Be Officially Free of FDA Regulation

September 23

Media erodes self-esteem and contributes to sleep deprivation
Close to 80% of college students have suffered at least one episode
Brain imaging research suggests negative consequences for the amygdala
Motivational interviewing improves attendance at group therapy sessions
In Today's Wired World, Kids Are At Risk of Melting Down–And Worse

September 19

U.S., Australia, and Canada Approve Endometrial Cancer Regimen
Single daily pill combines hypertension, cholesterol drugs
Drug With Androgen Deprivation Therapy Cut Risk of Death by 33% Compared With Placebo + ADT